Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellowship, Genetics, Harvard Medical School 1982 - 1986
  • Ph.D., Massachusetts Institute of Technology 1982
• 

  Duke Appointment History

  • Assistant Professor in Medicine, Medicine, Clinical Pharmacology, Medicine 2012 - 2019
• Expertise
• 

  Global Scholarship

  • Research

    • South Korea (Country) 
• Research
• 

  Selected Grants

  • Human EGFRvIII-specific BiTE for the treatment of Glioblastoma awarded by National Institutes of Health 2015 - 2020
  • Efficacy of dendritic cell vaccines targeting CMV antigens in glioblastoma awarded by University of Florida 2017 - 2019
  • Biodosimetry High-Throughput Test awarded by DxTerity Diagnostics 2017 - 2019
  • Bruce Burnett IPA awarded by National Institutes of Health 2018 - 2019
  • Systemic EGFRvIII-targeted bispecific antibody as immunotherapy for glioblastoma awarded by National Institutes of Health 2015 - 2019
  • Duke CTSA (UL1) awarded by National Institutes of Health 2013 - 2018
  • Bruce Burnett IPA awarded by National Institutes of Health 2017 - 2018
  • Immunology Quality Assesment Program Option 2 awarded by National Institutes of Health 2014 - 2017
  • Regulatory Guidance for Academic Research of Drugs and Devices awarded by University of North Carolina - Chapel Hill 2017
  • Point of Care Biodosimeter awarded by Department of Health and Human Services 2009 - 2016
  • Phase I CTU Task Area A: Administrative and Overal Clinical Operations Support and Concept Development awarded by National Institutes of Health 2014 - 2015
  • PTN Task Order #4: Hydroxyurea PK awarded by National Institutes of Health 2011 - 2014
  • Clinical Trial Planning in Pompe Disease awarded by National Institutes of Health 2013 - 2014
  • Novel Ondansetron Formulation for Combination Treatment of Psychostimulant Abuse awarded by National Institutes of Health 2009 - 2013
  • CTSA UL awarded by National Institutes of Health 2006 - 2012
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Berglund, JP, Szczepanski, N, Penumarti, A, Beavers, A, Kesselring, J, Orgel, K, Burnett, B, Burks, AW, and Kulis, M. "Preparation and Analysis of Peanut Flour Used in Oral Immunotherapy Clinical Trials." The Journal of Allergy and Clinical Immunology. in Practice 5, no. 4 (July 2017): 1098-1104.  Full Text
    • O'Reilly, EK, Hassell, NJ, Snyder, DC, Natoli, S, Liu, I, Rimmler, J, Amspacher, V, Burnett, BK, Parrish, AB, Berglund, JP, and Stacy, M. "ClinicalTrials.gov reporting: strategies for success at an academic health center." Clinical and translational science 8, no. 1 (February 2015): 48-51.  Full Text
    • Ruiz, J, Gilleskie, GL, Brown, P, Burnett, B, and Carbonell, RG. "Comprehensive hands-on training for influenza vaccine manufacturing: A WHO-BARDA-BTEC partnership for global workforce development." Biochemistry and Molecular Biology Education 42, no. 5 (September 10, 2014): 414-419.  Full Text
    • Ruiz, J, Gilleskie, GL, Brown, P, Burnett, B, and Carbonell, RG. "Comprehensive hands-on training for influenza vaccine manufacturing: a WHO-BARDA-BTEC partnership for global workforce development." Biochemistry and molecular biology education : a bimonthly publication of the International Union of Biochemistry and Molecular Biology 42, no. 5 (September 2014): 414-419.  Full Text
    • O'Reilly, EK, Blair Holbein, ME, Berglund, JP, Parrish, AB, Roth, M-T, and Burnett, BK. "Warning letters to sponsor-investigators at academic health centres - the regulatory "canaries in a coal mine"." Clinical and investigative medicine. Medecine clinique et experimentale 36, no. 6 (December 2013): E290-E296.
    • Matthay, MA, Anversa, P, Bhattacharya, J, Burnett, BK, Chapman, HA, Hare, JM, Hei, DJ, Hoffman, AM, Kourembanas, S, McKenna, DH, Ortiz, LA, Ott, HC, Tente, W, Thébaud, B, Trapnell, BC, Weiss, DJ, Yuan, JX-J, and Blaisdell, CJ. "Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012." American Journal of Respiratory and Critical Care Medicine 188, no. 3 (August 2013): 370-375. (Review)  Full Text
    • Morse, MA, Chaudhry, A, Gabitzsch, ES, Hobeika, AC, Osada, T, Clay, TM, Amalfitano, A, Burnett, BK, Devi, GR, Hsu, DS, Xu, Y, Balcaitis, S, Dua, R, Nguyen, S, Balint, JP, Jones, FR, and Lyerly, HK. "Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients." Cancer Immunology, Immunotherapy : Cii 62, no. 8 (August 2013): 1293-1301.  Full Text
    • Morse, MA, Chaudhry, A, Gabitzsch, ES, Hobeika, AC, Osada, T, Clay, TM, Amalfitano, A, Burnett, BK, Devi, GR, Hsu, DS, Xu, Y, Balcaitis, S, Dua, R, Nguyen, S, Jr, JPB, Jones, FR, and Lyerly, HK. "Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients." Cancer Immunology, Immunotherapy 62, no. 8 (2013): 1293-1301.  Full Text
    • Osada, T, Berglund, P, Morse, MA, Hubby, B, Lewis, W, Niedzwiecki, D, Yang, XY, Hobeika, A, Burnett, B, Devi, GR, Clay, TM, Smith, J, and Kim Lyerly, H. "Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects." Cancer Immunol Immunother 61, no. 11 (November 2012): 1941-1951.  Full Text  Link to Item
    • Adamo, JE, Bauer, G, Berro, M, Burnett, BK, Hartman, KA, Masiello, LM, Moorman-White, D, Rubinstein, EP, and Schuff, KG. "A roadmap for academic health centers to establish good laboratory practice-compliant infrastructure." Academic Medicine : Journal of the Association of American Medical Colleges 87, no. 3 (March 2012): 279-284.  Full Text
    • Kraus, VB, Burnett, B, Coindreau, J, Cottrell, S, Eyre, D, Gendreau, M, Gardiner, J, Garnero, P, Hardin, J, Henrotin, Y, Heinegård, D, Ko, A, Lohmander, LS, Matthews, G, Menetski, J, Moskowitz, R, Persiani, S, Poole, AR, Rousseau, J-C, Todman, M, and OARSI FDA Osteoarthritis Biomarkers Working Group, . "Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis." Osteoarthritis and Cartilage 19, no. 5 (May 2011): 515-542.  Full Text
    • Berro, M, Burnett, BK, Fromell, GJ, Hartman, KA, Rubinstein, EP, Schuff, KG, and Speicher, LA. "Support for investigator-initiated clinical research involving investigational drugs or devices: The clinical and translational science award experience." Academic Medicine 86, no. 2 (2011): 217-223.  Full Text
    • Morse, MA, Hobeika, AC, Osada, T, Berglund, P, Hubby, B, Negri, S, Niedzwiecki, D, Devi, GR, Burnett, BK, Clay, TM, Smith, J, and Lyerly, HK. "An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer." The Journal of Clinical Investigation 120, no. 9 (September 2010): 3234-3241.  Full Text  Open Access Copy
    • Hubby, B, Talarico, T, Maughan, M, Reap, EA, Berglund, P, Kamrud, KI, Copp, L, Lewis, W, Cecil, C, Norberg, P, Wagner, J, Watson, A, Negri, S, Burnett, BK, Graham, A, Smith, JF, and Chulay, JD. "Development and preclinical evaluation of an alphavirus replicon vaccine for influenza." Vaccine 25, no. 48 (2007): 8180-8189.  Full Text
    • Reap, EA, Morris, J, Dryga, SA, Maughan, M, Talarico, T, Esch, RE, Negri, S, Burnett, B, Graham, A, Olmsted, RA, and Chulay, JD. "Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus." Vaccine 25, no. 42 (2007): 7441-7449.  Full Text
• Teaching & Mentoring
• 

  Recent Courses

  • CRP 254: Research Management 2019

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.